Içten Elçin, Giridhar Arun, Nagy Zoltan K, Reklaitis Gintaras V
School of Chemical Engineering, Purdue University, Forney Hall of Chemical Engineering, 480 Stadium Mall Drive, West Lafayette, Indiana, 47907, USA.
AAPS PharmSciTech. 2016 Apr;17(2):284-93. doi: 10.1208/s12249-015-0348-3. Epub 2015 Jun 17.
The features of a drop-on-demand-based system developed for the manufacture of melt-based pharmaceuticals have been previously reported. In this paper, a supervisory control system, which is designed to ensure reproducible production of high quality of melt-based solid oral dosages, is presented. This control system enables the production of individual dosage forms with the desired critical quality attributes: amount of active ingredient and drug morphology by monitoring and controlling critical process parameters, such as drop size and product and process temperatures. The effects of these process parameters on the final product quality are investigated, and the properties of the produced dosage forms characterized using various techniques, such as Raman spectroscopy, optical microscopy, and dissolution testing. A crystallization temperature control strategy, including controlled temperature cycles, is presented to tailor the crystallization behavior of drug deposits and to achieve consistent drug morphology. This control strategy can be used to achieve the desired bioavailability of the drug by mitigating variations in the dissolution profiles. The supervisor control strategy enables the application of the drop-on-demand system to the production of individualized dosage required for personalized drug regimens.
先前已报道了为制造熔体基药物而开发的按需滴加系统的特点。本文介绍了一种监督控制系统,其旨在确保高质量熔体基固体口服制剂的可重复生产。该控制系统通过监测和控制关键工艺参数(如液滴大小、产品和工艺温度),能够生产具有所需关键质量属性的单个剂型:活性成分的量和药物形态。研究了这些工艺参数对最终产品质量的影响,并使用拉曼光谱、光学显微镜和溶出度测试等各种技术对所生产剂型的性质进行了表征。提出了一种结晶温度控制策略,包括受控温度循环,以调整药物沉积物的结晶行为并实现一致的药物形态。该控制策略可用于通过减轻溶出曲线的变化来实现药物所需的生物利用度。监督控制策略使按需滴加系统能够应用于个性化药物治疗方案所需的个体化剂型的生产。